NCT06083324 EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
| NCT ID | NCT06083324 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-02-03 |
| Primary Completion | 2027-01-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-02-03 with a primary completion date of 2027-01-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.
Eligibility Criteria
Inclusion Criteria: 1. Age 20-89 years 2. Women of child-bearing potential must verbally confirm lack of pregnancy prior to enrollment. They should also consent to use adequate contraception during the course of the study. 3. Participants must be determined capable of engaging in resistance training by exercise personnel and/or study PI 4. Participants must complete an assessment by EOC staff and be determined safe to engage in the workout regimen by the study exercise personnel. 5. Individuals not deemed safe to participate in the standard EOC exercise program will be referred to physical therapy or elsewhere Exclusion Criteria: 1\. Severe arthritic, joint, cardiovascular, or musculoskeletal condition that would interfere with exercise program
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06083324 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 89 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06083324 currently recruiting?
Yes, NCT06083324 is actively recruiting participants. Contact the research team at samantha.campbell@ahn.org for enrollment information.
Where is the NCT06083324 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT06083324 clinical trial?
NCT06083324 is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.